GlobeNewswire

Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
10/11/2026
KANSAS CITY, Kan., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop next-generation [...]
MannKind to Participate in Upcoming Investor Conferences
10/11/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Chris [...]
Intellia Therapeutics to Present at Jefferies Global Healthcare Conference in London
10/11/2026
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
10/11/2026
Two major federal awards totaling nearly $16.8 million will support research over a period of up to five years, including research examining how SilverCloud by Amwell, the digital cognitive behavioral therapy program on [...]
Spyre Therapeutics to Participate in Upcoming Investor Conferences
10/11/2026
WALTHAM, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology [...]
Aradigm appoints Tim Wentworth to board of directors
10/11/2026
Former CEO of Walgreens Boots Alliance and Express Scripts brings expertise in high-cost drug management, patient pharmacy care, supply chain and purchaser economics as Aradigm scales its cell and gene therapy platform [...]
Novartis ranks first place in 2026 Access to Medicine Index
10/11/2026
Novartis retains first place ranking among 20 sector peers for efforts to improve access to medicines First company to achieve No. 1 rank across all Technical Areas since Index began in 2008, achieving R&D score [...]
VivoSim Labs to Showcase Multiparametric Human 3D Tissue Safety Data at the American College of Toxicology (ACT) 47th Annual Meeting
10/11/2026
Company to feature two scientific poster presentations highlighting that its multiparametric approach delivers superior predictive power for both its DILI risk stratification and gastrointestinal toxicity profiling [...]
Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
10/11/2026
CHARLESTOWN, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand
10/11/2026
Collaboration builds on Dosy Health’s established relationships with Mahidol University, Thammasat University and hospitals within the BDMS network, supporting planned distribution and commercialization in Thailand [...]
Sustained health equity progress lifts Boehringer to rank 6th in Access to Medicine Index
10/11/2026
Boehringer Ingelheim progresses to 6 th place in the 2026 Access to Medicine Index Company performs above average across all three assessed areas, with significant progress in Governance of Access and Product Delivery [...]
Armor Health Partners with Antidote to Advance AI-Powered Clinical Innovation Across Correctional Healthcare
10/11/2026
AI-driven sick call and clinical intervention tools highlight Armor’s commitment to improving care, supporting providers, and strengthening operational performance for its client partners MIAMI, Nov. 10, 2026 (GLOBE [...]
Supernus, Inc. to Participate in the 2026 Jefferies Global Healthcare Conference in London
10/11/2026
ROCKVILLE, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Supernus, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases [...]
CRISPR Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
10/11/2026
ZUG, Switzerland and BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will participate in a fireside chat at the 2026 Jefferies [...]
Vittoria Biotherapeutics Announces FDA RMAT and Orphan Drug Designations for Senza5 CART5 (VIPER-101) in T-Cell Lymphoma
10/11/2026
RMAT designation provides early and frequent FDA engagement to support planned pivotal development of Senza5 CART5 Therapy may be eligible for priority review and accelerated approval if applicable criteria are met [...]
Conexeu Sciences Launches Human Collagen Initiative for Regenerative Aesthetics as GLP-1 Drives Demand for Tissue Restoration
10/11/2026
CXU™ formula already evaluated with human collagen in the 12-month P.R.O.O.F.™ preclinical study; first pilot batch of Conexeu’s own human collagen met predefined Company specifications Highlights Conexeu has launched a [...]
Lite Strategy Reports Fiscal 2027 First Quarter Financial Results
10/11/2026
Share Repurchases Retire a Further 6.8% of Outstanding Shares Below Net Asset Value Cash Used in Operations Down 52% and G&A Expenses Down 24% Year over Year Balance Sheet Remains Debt-Free SAN DIEGO, Nov. 10, 2026 [...]
Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth
10/11/2026
Revenue up 25% year-over-year and 21% sequentially, marking third consecutive quarter above $1 million Higher-margin cartridge sales grew 32% year-over-year and 35% sequentially, representing 61% of total revenue Gross [...]
CytoDyn and QLHC Advance Leronlimab into Two New PRE-I-SPY Studies in Metastatic Triple-Negative Breast Cancer
10/11/2026
VANCOUVER, Washington, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum